Breaking News Instant updates and real-time market news.

This morning, Citi analyst Timothy Thein downgraded Paccar (PCAR) to Neutral, citing a lack of catalysts, while his peer at Susquehanna initiated coverage of the stock with the same rating. However, not all on Wall Street are as bearish. JPMorgan analyst Ann Duignan argued that the weakness in the shares since Tesla's (TSLA) Semi truck reveal is overdone, and reiterated a buy-equivalent rating on the stock. WEAKNESS OVERDONE: In a research note to investors, JPMorgan's Duignan pointed out that Paccar's shares have underperformed the S&P Machinery Index by 4.7% since the unveiling event for Tesla's Semi truck. The analyst views the reaction in Paccar shares as overdone, saying the likelihood of "significant disruption in the near to mid-term is limited, at most." If Tesla is to succeed in transforming the trucking industry to electric, it will likely need to partner with a company like Paccar, Duignan contended, adding that such a partnership may be a net positive for both companies. Overall, the analyst does not view the electric Semi as significant threat and rather believes it could be an upside catalyst. Duignan reiterated an Overweight rating and an $83 price target on Paccar shares. MOVING TO THE SIDELINES: Meanwhile, Citi's Thein downgraded Paccar to Neutral saying that despite the stock's year to date underperformance, he no longer sees catalysts in place to warrant a Buy rating. While the analyst expects trucking fundamentals in most of the company's major geographies to remain solid through 2018, his concern revolves more around the target multiple, as history has exhibited a fairly consistent pattern of multiple compression as North America build rates eclipse "trend" levels. Additionally, Thein pointed out that risk from electric vehicles is likely overplayed, but the overhang is still a concern. He lowered his price target on Paccar shares to $75 from $81. His peer at Susquehanna also initiated coverage of the stock with a Neutral rating and a $75 price target. While analyst Brendon Mason acknowledged Paccar's superior track record and marketplace standing, he believes there are other OEMs who are better positioned to benefit more vigorously from improving industry growth at this time. PRICE ACTION: In morning trading, shares of Paccar have gained about 1.3% to $69.40.

JPMorgan analyst Ann Duignan notes that according to ACT Research, Class 8 retail truck sales were 23,684 units in October, up 28% year-over-year but down 4% year-to-date, while net orders were 36,033 units, up 159% year-over-year and up 55% year-to-date. Truck demand has the largest incremental impact on Navistar (NAV), Paccar (PCAR), Cummins (CMI), Allison Transmission (ALSN) and Eaton (ETN), Duignan tells investors in a research note. She points out that the truck and truck components group has outperformed year-to-date, but underperformed more recently on Tesla's (TSLA) Class 8 electric semi announcement.

11/29/17

SBSH

11/29/17DOWNGRADETarget $75SBSHNeutral

Paccar downgraded to Neutral from Buy at Citi

Citi analyst Timothy Thein downgraded Paccar to Neutral saying he no longer sees catalysts in place to warrant a Buy rating. The analyst expects multiple compression in 2018 as North America truck build rates eclipse "trend" levels. He cut his price target for the shares to $75 from $81.

11/29/17

JPMS

11/29/17NO CHANGETarget $83JPMSOverweight

Paccar weakness since Tesla Semi reveal overdone, says JPMorgan

Paccar (PCAR) shares have underperformed the S&P Machinery Index by 4.7% since the reveal of Tesla's (TSLA) Semi truck, JPMorgan analyst Ann Duignan tells investors in a research note titled "Why Electric Vehicles Could Be An Opportunity." The analyst views the stock reaction as overdone, saying the likelihood of "significant disruption in the near to mid-term is limited, at most." If Tesla is to succeed in transforming the trucking industry to electric, it will likely need to partner with a company like Paccar, Duignan writes. She does not view Tesla's Semi as a significant threat and feels, rather, that it could be an "upside catalyst." The analyst reiterates an Overweight rating on Paccar with an $83 price target. Citi this morning downgraded the shares.

11/29/17

SUSQ

11/29/17INITIATIONTarget $75SUSQNeutral

Paccar initiated with a Neutral at Susquehanna

Susquehanna analyst Brendon Mason initiated Paccar with a Neutral rating. The analyst acknowledges the company's superior track record and marketplace standing but believes there are other OEMs who are better positioned to benefit more vigorously from improving industry growth at this time. Mason has a $75 price target on Paccar shares.

TSLATesla

$317.55

0.74 (0.23%)

11/20/17

JPMS

11/20/17NO CHANGETarget $185JPMSUnderweight

JPMorgan still cautious on Tesla's ability to ramp Model 3 volume

Diving the Model 3 makes "quite an impression - it is a veritable display of technology on wheels with a high coolness factor," JPMorgan analyst Ryan Brinkman tells investors in a research note titled "Model 3 Test Drive Confirms No Trouble Lining Up Buyers, But We Remain Cautious on Ability to Profitably Ramp Volume." The analyst believes progress, or lack thereof, in profitably ramping Model 3 volume will be the key driver of Tesla shares into 2018, not expectations for future products such as the semi-truck or Roadster. He still sees challenges in the company hitting production targets and attaining a 25% gross margin. Brinkman keeps an Underweight rating on Tesla shares with a $185 price target.

11/21/17

MSCO

11/21/17NO CHANGETarget $379MSCOEqual Weight

Tesla could rise above $400 per share in next few months, says Morgan Stanley

Morgan Stanley analyst Adam Jonas said he expects Tesla shares to be extremely volatile in 2018. He assumes that Tesla's battery module production bottlenecks may be resolved in weeks, which could result in the stock price rising to $400 or more over the next few months, he tells investors. However, following a "hypothetical 1H18 pop," he could see longer-term risks in the story and more serious headwinds to come to the forefront of investors attention, Jonas adds. The analyst maintains an Equal Weight rating and $379 price target on Tesla shares, which closed yesterday at $308.74.

AT&T Mobility has reached a tentative agreement with the Communications Workers of America in Mobility Orange contract negotiations. The four-year agreement, which will be submitted to the union's membership for a ratification vote in coming days, covers about 20,000 employees in 36 states and the District of Columbia - AT&T's Mobility Orange unit, which encompasses CWA Districts 1, 2-13, 4, 7 and 9.

Pfizer announced that the United States FDA has approved IXIFI, a chimeric human-murine monoclonal antibody against tumor necrosis factor, as a biosimilar to Remicade for all eligible indications of the reference product. The FDA has approved IXIFI as a treatment for patients with rheumatoid arthritis, Crohn's disease, pediatric Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, and plaque psoriasis.

Western Alliance Bancorporation announced that during the first quarter of 2018 Robert Sarver will transition from Chairman and CEO to Executive Chairman. In conjunction with Sarver's change in role, Ken Vecchione will be promoted to Chief Executive Officer, Dale Gibbons to Vice Chairman and Chief Financial Officer, and James Haught to President and Chief Operating Officer, all effective April 1, 2018.

Aqua America announced that President and CEO Christopher H. Franklin has been elected chairman of the board, effective Jan. 1, 2018. Franklin became CEO in July 2015 and has served on the board of directors since October 2015. He succeeds Nicholas DeBenedictis, former CEO, who will continue to serve on the board as chairman emeritus.